Chemotherapy patch being developed; FDA grants IDE to TherOx's cardiology device;

> Caltech student Teo Wilkening and professors are developing a patch for the painless delivery of chemotherapy. More

> Irvine, CA's TherOx announced it received an Investigational Device Exemption (IDE) from the FDA to conduct a safety study of its Supersaturated Oxygen Therapy, which is intended to reduce the size of lesions that form as a result of tissue death following a heart attack. The 100-person study will support the device's PMA application. More

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.